beta

ABEOW

Abeona Therapeutics, Inc.

Abeow

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

Market Cap: 47.1 Million

Primary Exchange: NASDAQ

Website: http://www.abeonatherapeutics.com

Shares Outstanding: 0

Float:

Dividend: (%)

Beta: -0.736468502663384

Sector: Health Technology

Industry: Pharmaceuticals: Generic

Ethical Flags

Longest drawdown: 296 trading days

From: 2015-05-19 To: 2016-10-19

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud